Bass, I R <br/><br/>
Novel breast cancer treatment leads to hyperglycaemia.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  05 2020 
 - 893-894 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-5491 
<br/><br/><label>Standard No.: </label>10.1111/dme.14281  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Blood Glucose--metabolism<br/>Blood Glucose Self-Monitoring<br/>Breast Neoplasms--complications<br/>Class I Phosphatidylinositol 3-Kinases--genetics<br/>Female<br/>Fulvestrant--therapeutic use<br/>Humans<br/>Hyperglycemia--chemically induced<br/>Monitoring, Ambulatory<br/>Phosphoinositide-3 Kinase Inhibitors--adverse effects<br/>Prediabetic State--complications<br/>Thiazoles--adverse effects